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Abstract 
 
 For years medication has become a normalized part of American Culture. Americans 
have begun to take medications for many different ailments, simultaneously even at times. The 
youth of our society have been of no exception to this shift in culture. With the idea of mental 
illness becoming less and less taboo, children are diagnosed with many mental illnesses and are 
often treated with medication. While some have grown accustomed to this idea of treating our 
youth with medication, many have become alarmed by it. The threat of unknown lasting 
consequences and harsh side effects have begun to instill fear in parents and professionals 
alike. So much so that countries such as Canada and Great Britain have begun to pass laws 
preventing children from being able to be prescribed certain more serious medications. Despite 
this fact there are many who stand by the effectiveness and safety of medication in treating 
mental illness in children claiming that it is unethical to deny children a treatment that is known 
to ease their suffering. However, there is much work being done to come up with a possibly 
even more effective form of treatment that combines medication with less invasive treatment 
options.  
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The Issue 
Treating mental illness is not a new concept for the United States. Throughout the years 
we as a society have evolved in order to better treat those suffering from various mental 
illnesses. Mental illness is so widely accepted now that it has become part of the mainstream in 
our culture. There is significantly less judgment today from society upon those who are being 
medicated for mental illness than there was many years ago. But has this gone too far? Many 
are starting to believe that we as a society have swung too far in the opposite direction. These 
people believe that mental illness medication has become such of the norm that it is often 
overused. This idea becomes particularly alarming when you look at the increasing amount of 
children that have been placed on medication for some sort of mental illness. 
        When it comes to the issue of over medicating children for mental illness, there are 
many different things to consider. Firstly, what are the actual numbers of children being 
medicated? The number has certainly increased over the years, but by how much is an 
important question when looking at this topic. It is also important to look at the effects that 
long term medication may have on children. Additionally many question the necessity of 
medicating children. Other possible solutions besides medication must also be looked at in 
order to determine the amount of need there is for such medication. The Diagnostic Statistical 
Manual is of great importance to this topic as well. This manual serves as the main guideline for 
the diagnosis and treatment for mental illnesses and is used in a wide range of professions such 
as psychologists and psychiatrists. There is a significant amount of research that has been 
completed in regards to this topic. I intend to look at this research in order to come up with the 
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answers to many of the above questions. I also hope to come up with a general idea of society’s 
feelings on this topic. 
Rising Trends 
When examining this topic there is one thing that cannot be disputed with and that is 
the number of children, both past and present, being treated for mental illnesses and disorders 
through medication. There have been a slew of recent studies detecting the rise of this trend 
and their results can be surprising. Perhaps the most astonishing of these numbers come from 
those of children who are being medicated and diagnosed with ADHD. According to a Mayo 
Clinic study, children between the ages of 5 and 19 have at least a 7.5% chance of being found 
to have ADHD. This statistic amounts to nearly 5 million kids (Kluger, 2008). A similar study with 
data collected between 2005 and 2011 found likewise results. This data showed that 6.8% of 
children ages 1-17 were currently diagnosed with ADHD. It was determined that ADHD was the 
most prevalent current diagnosis among children of ages 13-17 years. It was also determined 
that boys are more likely than girls to be diagnosed with ADHD, behavior problems, autism 
spectrum disorders and Tourette syndrome (Zuvekas, 2006). 
Another common diagnosis received by children is for depression, anxiety and 
behavioral or conduct problems. Up until recent years many psychologists weren’t even certain 
of rather or not children could suffer from mental illnesses the way adults do. Today, it is 
discovered that up to 10% of all American children suffer from some mental illness (Kluger, 
2008). The Center for Disease Control and Prevention (Center for Disease Control and 
Prevention, 2014) published an article containing information from a report by the National 
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Research Council and Institute of medicine titled Preventing mental, emotional and behavioral 
disorders among young people: Progress and possibilities (2009).  
The information from this article showed there are an estimated 13-20 percent of 
children living in the United States experience a mental disorder in any given year. This roughly 
equates out to 1 out of 5 children each year. An additional finding shows that in any given year 
there is an estimated $247 billion spent on childhood mental disorders. The CDC concluded its 
article on the subject by stating “children’s mental disorders are an important public health 
issue for the United States (Center for Disease Control and Prevention, 2014). 
Another recent report featured on the CDC’s website stated that as many as 10,000 
toddlers may be receiving psychostimulant medication such as methylphenidate or more 
commonly known as Ritalin. The National Center for Health and Statistics reports from data 
collected between 2011-2012 that 7.5% of U.S. children between the ages of 6 and 17 were 
taking medication for “emotional or behavioral difficulties.” (Zito, 2000). 
Conduct/Behavioral problem, anxiety and depression are the other most common 
illnesses diagnosed in children in the United States other than ADHD. One study shows that 
adolescent girls are more likely than boys to be diagnosed with depression or an alcohol use 
disorder. The data collected from this study determined that 3% of children ages 13-17 years 
currently were diagnosed with anxiety and 2.1% of children ages 13-17 years were currently 
diagnosed with depression. Additionally it was shown that  3.5% of children between those 
same ages were currently diagnosed with behavioral or conduct problems (National Institute of 
Mental Health, 2014).  
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Many of the numbers shown throughout the studies are certainly staggering. However, 
they become even more intriguing when compared to the numbers from the past. For example, 
the CDC reports a five-fold increase in the number of children under 18 on psychostimulants 
from the years 1988-1994 to 2007-2010. The most recent rate of this being 4.2%. In addition to 
this, the rate of antipsychotic prescriptions for children has increased six-fold over this same 
time period according to a study of office visits within the National Ambulatory Medical Care 
Survey (Leibert, 2013).  
The report goes on to estimate that 1.3% of children are on antidepressants. There are 
some numbers that have been decreasing ever so slightly. For example, in children under the 
age of 5, psychotropic prescription rates had reached their peak at 1.45% in the years 2002-
2005 and then declined to 1.00% in the years 2006-2009. One study raised the question of 
possible under treatment for ADHD stating “Hearing that 7.5% of children are on medication 
(4.2% being on psychostimulants) seems stunning, but knowing that 11% of children have a 
diagnosis of ADHD raises a possibility of under-treatment (Leibert, 2013). 
The CDC has been very hands-on when it comes to this topic as they have completed 
their own study regarding to continuous rise of diagnosis and treatment for ADHD. The results 
of this study concluded that over an 8 year period (2003-2004 to 2011-2012) two million more 
children in the United States have been diagnosed with ADHD and one million more children in 
the United States were taking medication for ADHD over this time period. The CDC remains 
concerned with the younger and younger children who are taking medication for ADHD. 
According to their study the CDC determined that half of all children diagnosed with ADHD are 
diagnosed by age 6. Additionally, children with more severe ADHD tend to be diagnosed even 
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earlier with nearly half of them being diagnosed by age 4 based on parent reports (Center for 
Disease Control and Prevention, 2014).  
When viewed in percentages, the amount of children diagnosed and taking medication 
can seem small. However, the CDC equated the percentages to numbers which gives the 
average person a better idea of how many children in the United States this issue is affecting. 
According to the CDC’s study 6.4 million children ages 4-17 had been diagnosed with ADHD by a 
health care provider from 2011-2012 with 3.4 million of these children taking medication for 
their ADHD. This is a 42% increase from 2003-2011 (Center for Disease Control and Prevention, 
2014).  
This issue has caught the attention of many different groups across the United States. 
National Public Radio posted their own article up on their website with statistics given on the 
increase in medication if children. The article stated that families are increasingly opting for 
medication as the form of treating their kids when diagnosed with a mental illness. The article 
goes on to say that two-thirds of children with a current mental illness diagnosis are being 
medicated. This statistic shows a 28% increase from 2007 to 2011 (npr). 
State by State Comparison 
Many of these studies examine the United States data as a whole. However, it is also 
important to examine these statistics on a state by state basis. A study titled State-based 
Prevalence Data of Parent Reported ADHD Medication Treatment sheds much light on this. This 
article displays two color coded maps of the United States as well as each state’s data from 
both the years 2007 and 2011. One map and data set include the percentages of children being 
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medicated for ADHD and the other depicts the percentages of children diagnosed and being 
medicated for ADHD. 
The states with the highest percentage of children being medicated (9% and up) 
includes Arkansas, North Carolina, Indiana, Iowa, Kentucky and Louisiana with Kentucky and 
Louisiana being the highest at 10.1 (Kentucky) and 10.4 percent (Louisiana). The states with the 
lowest percentages (between 3 and 5 percent) include Alaska, California, Hawaii, Utah and 
Nevada with Nevada being the lowest with 2% in 2011. Most states experienced an increase in 
prevalence of ADHD medication from 2007-2011. Although no states experienced a significant 
decrease in prevalence between there were a few states that experienced a dramatic increase. 
Montana, Iowa and Texas almost doubled in their percentages within the 4 year time frame 
(State-based, 2014). 
The next data set and map examines the amount of children who are being treated with 
medication of those who are diagnosed with ADHD on a state by state basis. This data set also 
examines this information from the years 2007 and 2011. The States that medicate most of 
their diagnosed children include Alabama, Nebraska, North Carolina, North Dakota, Indiana, 
Iowa, Kansas, Louisiana, Missouri, Texas, Tennessee and Wisconsin (State-based, 2014). 
While some states in this data set saw an increase in medication of their diagnosed 
children between 2007 to 2011 there were also many states that saw a decrease in the 
medicating of diagnosed children within the time frame. Some of those states include Rhode 
Island, South Carolina, Georgia and Illinois. The states that had the least amount of diagnosed 
and medicated children included Alaska, Colorado, Nevada, Washington D.C., Hawaii, Illinois, 
Oregon, South Carolina and Utah. All of those states had a percentage of less than 65% of their 
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diagnosed ADHD children being medicated. The states with the least included Hawaii at 53.1% 
and Washington D.C. at 53.2% (Center for Disease Control and Prevention, 2014) 
The article posted on the National Public Radio website also took note of the significant 
difference in regional ADHD diagnosis in the United States. For example, 15% of kids in 
Arkansas have had an ADHD diagnosis. This differs substantially from the 9% diagnosed in 
Maryland and 5% diagnosed in Nevada (Npr). 
Process of Diagnosis 
An important question to ask after examining these growing numbers is “who is 
prescribing the medication?” and “How is this happening?” According to a diagnosis guide for 
parents of children with bipolar disorder, a specialist is not always needed to diagnose and 
prescribe medication for children. Often times a diagnosis and treatment can be completed by 
the child’s primary care physician or pediatrician. However, it is strongly recommended that the 
parents seek a second opinion from a trained psychiatrist before placing a child on any 
medication (Parents’ Medguide, 2013). 
In another article posted on the National Institute of Mental Health’s website, it is 
recommended that parents who are concerned that their child may be showing symptoms of a 
mental illness, talk to the child’s pediatrician. Furthermore, the article recommends that the 
child is evaluated by a specialist if that is what the child’s primary care physician feels is best. 
Specialists can include anyone from psychiatrists, psychologists, social workers, psychiatric 
nurses and behavioral therapists (Hirsch, 2013.) 
The National Institute of Mental Health also describes the usual process that a 
psychiatrist will go through in order to diagnose a child. First the signs and symptoms of the 
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child are carefully examined and observed. Often times a doctor will try and rule out other 
possible causes for the symptoms before diagnosing them with a specific mental illness 
(National Institute of Mental Health, 2014). This is usually where the Diagnostic Statistical 
Manual (DSM) comes into play. Each mental illness described in this manual has specific 
guidelines for specialists to follow when making a diagnosis. For example, a specific amount of 
symptoms may need to be present or the illness has to have presented itself before or after a 
certain age in order for that diagnosis to be considered plausible (Diagnostic Statistical Manual, 
2014).  
Although the DSM serves as a guideline for diagnosis, there is no one specific test to 
determine if a child has a mental illness. This is especially true for the diagnosis of ADHD. 
Determining of a child has ADHD is a several-step process. Diagnosis can also be difficult when 
many mental illnesses display overlapping symptoms (CDC symp and diag). 
The Dangers of Medication 
Upon looking at the available facts it is easy to see that the amount of youth that is 
taking medication is abundant. But these numbers still leave a question as to why do some 
people believe these large numbers are such an issue. For starters, the article titled Medicating 
Young Minds asks “Are we adults raising Generation Rx?” The numbers of children taking 
medication for some sort of mental disorder would certainly support this. However the real 
question is “How necessary is medication in cases of mental disorders in children? And what 
problems could over-medicating the youth of our country cause?” 
Many have begun to wonder how safe it is to treat children with psychotropic drugs. 
Although a few of the newer drugs have been developed and approved specifically for youth, 
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the majority of drugs used on children have only been approved by the FDA for adults. Doctors 
are able to get away with using these drugs on children because they are using them as what’s 
called “off label.” This practice is becoming more and more common with younger and younger 
patients. One example of this is a study completed in Canada that showed in results that 
Canadian doctors made 141,000 recommendations for Paxil to patients under 19 for which the 
FDA has not approved the drug for. Although the practice of “off label” prescribing is common 
and completely legal, many still view it as risky. Remi Quirion, the director of the Institute of 
Neuroscience in Canada stated “For kids, we don’t know as much about what dose we should 
use and what could be the long-term impact of the treatment we’re giving” (Kluger, 2008). 
The reason why many of these medications that are approved for adults cannot be 
approved for is because of the differences between young brains and adult brains. The brains of 
young children change and develop at rapid speed. Many studies have shown that young brains 
that are still developing can be very sensitive to medications. Young brains also have 
developmental differences in the way that they metabolize or in other words, how their bodies 
process such medications. A childhood mental health fact sheet displayed on NIMH warns that 
doctors should “carefully consider the dosage of these medications to each child.” The article 
goes on to say that more research is needed on the effects of these medications on the brains 
of children. Due to the fact that many psychotropic medications have not been studied in their 
use with children they have continued to not be approved by the FDA for children (National 
Institute of Mental Health, 2014). 
Some countries are beginning to question the practice of “off label” prescribing. British 
drug regulators have recently recommended against the use of Paxil, Zoloft and three other 
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common SSRI’s (Selective Serotonin Reuptake Inhibitor) for children. The drug regulators cited 
their main reason for this as the links that these medications have to suicidal thoughts and self-
harm when used by children. Since this, Canada has begun to examine their use of these 
medications on children as well. Health Canada has warned health-care professionals against 
prescribing Paxil to anyone under 18. It has also begun to warn against the use of Effexor with 
pediatrics which is a Selective serotonin and norepinephrine reuptake inhibitor (SNRI) (Kluger, 
2008). 
This reinforces the fact that the medical community has a growing concern about what 
psychotropic drugs can do to still developing brains. The fact that the United States has not 
begun to question its drug use on children could be chalked up to the fact that Western culture 
is a quick-fix culture. Many people in the United States will try and find the simplest solution to 
any problem they have regardless of what the long-term consequences may be. Dr. Glen Elliot 
is director of the Langley Porter Psychiatric Institute’s Children’s Center at the University of 
California in San Francisco. He believes that “The problem is that our usage has outstripped our 
knowledge base…we’re experimenting on these kids without tracking the results. “ (Kluger, 
2008). 
Many people have also begun to wonder if all of this medicating of our youth is 
interfering with a child’s normal development. This is particularly the case when symptoms of a 
disorder may be very mild. For example, a child who is somber but not depressed or a child who 
is antsy but not clinically hyperactive may not truly require medication. Stephan Hinshaw, the 
chairmen of psychology at the University of California in Berkley, believes that if we do not start 
assessing each case carefully we may start to medicated and try and change normal variations 
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in behavior. If all eccentric kids were medicated to be “normal” the world would be “a far less 
interesting place” he continues. Some doctors also worry that by medicating a child’s 
developing brain, you may be ruining the very thing that could save it. For example, if a child 
with anxiety is prescribed antianxiety medication at a young age they may never have the 
chance to develop normal coping skills to manage stress on their own without drugs (Kluger, 
2008). 
The Diagnostic and Statistical Manual currently in its fifth edition (DSM-5) is designed to 
help clinicians diagnose and treat various mental illnesses. The DSM-5 states under its section 
on ADHD that 6 symptoms must be present in order for a child to be diagnosed with ADHD. 
However, many doctors may use their own discretion when it comes to the amount of 
symptoms present. Therefore, it can be easy for the medicating of what is simply a normal 
variation in behavior where another treatment option could be used that doesn’t involve 
medication (Diagnostic Statistical Manual, 2013). 
The DSM-5 has also added many extras in its newest addition specifically for children 
due to the increasing number of them being diagnosed with disorders and treated with 
medication. The DSM-5 also changed its requirement for symptoms present from prior to 7 
years of age to prior to 12 years of age. However, the DSM-5 also states that some conditions 
found in children are in need of more research and clinical experience before being considered 
a main disorder in children such as non-suicidal self-injury (Diagnostic Statistical Manual, 2013).  
The Issue of Side Effects 
One obvious issue that comes along with medicating youth is the side effects to these 
medications. One of the major side effects that is feared are the suicidal thoughts and actions 
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that can accompany antidepressant medication when taken by children. There have been 
several studies whose data supports this claim but there are also several that dismiss it. The 
FDA has developed a ‘black box” warning label on antidepressants that indicates they may 
cause suicidal thoughts when taken by children or adolescents. This type of warning label is the 
most serious type when it comes to prescription drug labeling (Antidepressants, 2013). 
Most children who are diagnosed with bipolar disorder are prescribed a mood stabilizer. 
These drugs have their fair share of side effects as well. Mild side effects of these medications 
include weight gain, nausea, blurred vision, slurred speech and hair loss. These types of 
medications also come with long term concerns such as decreased thyroid function and 
hyperparathyroidism which can cause kidney stones (bipolar). Due to the fact that many of 
these medications come with such side effects, many doctors recommended only using 
medication as a treatment option when the benefits outweigh the risks (National Institute of 
Mental Health, 2013). 
 
The Benefits of Medication 
 Although there are many reasons for why children should not be placed on psychotropic 
medication for mental illness, the numbers are clearly showing that a staggering amount of 
children continue to be medicated. This is most likely due to the amount of research being 
completed that proves and discusses the many benefits of medicating children for such 
illnesses. Research supporting this fact has been increasing and many experts and doctors are 
working hard to clear the bad reputation that many medications have when used with children.  
One article states that some children truly need medication in order to manage the 
severe and difficult problems that their mental illness causes them. The article goes on to say 
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that without such medication being used, these children suffer very serious and possibly even 
dangerous consequences (National Institute of Mental Health, 2013). The CDC published a 
similar article discussing treatment options for ADHD specifically. This article stated that 
receiving the proper treatment for ADHD is very important and children who do not receive 
adequate treatment via medication for their ADHD may suffer from serious negative 
consequences. These consequences can include things like low self-esteem, social failure, 
academic failure, substance abuse and an increase in the risk of antisocial and criminal behavior 
(Center for Disease Control and Prevention, 2013). When depression is left untreated it has a 
lifetime suicide rate of 15%. Statistics such as these lead many to believe that medication is the 
answer for those with mental illness regardless of their age (Huefner, 2014).  
Many parents are often concern that the treatment of mental illness with medication 
could cause drug dependence later in life when used by their children.  However, multiple 
studies have shown that this this not the case. These studies followed children with ADHD for 
ten years or more and support the conclusion that the clinica. use of psychostimulant 
medications does not increase the risk of substance abuse later in life. Additionally, many 
studies have further shown that those with ADHD who are not effectively treated with 
medication during childhood and adolescence have a greatly increased risk of developing a 
significant alcohol or drug abuse problem later on in their life. Furthermore, when children with 
ADHD are treated with medication, this study proved that the risk of drug or alcohol abuse late 
on in life is reduced to the same of individuals who do not have ADHD (Children and Adults with 
ADHD, 2013). 
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An article posted on a website that solely discusses mental health in children 
acknowledges the fact that many parents want to avoid medication or are scared to use 
medication as a treatment option. However, the prognosis of a child’s illness is proven to be 
brighter and more optimistic with proper treatment that often includes medication. 
Additionally, if a child does not receive the proper care for their mental illness, the illness may 
continue on into adulthood. When this occurs it creates a very high risk for further issues such 
as substance abuse, antisocial behavior or even suicide. Giving the correct diagnosis and most 
effective treatment option (including medication) is linked to an outlook for a healthy and 
positive life as an adult (Antidepressants, 2013).Many experts are actually more concerned with 
the idea of under medicating children with mental illnesses rather than over medicating them 
and feel it is of a bigger risk. The belief that treating moire kids for mental illness could reduce 
the prevalence of mental illness in adults also favors in the side of medication intervention 
(Kluger, 2008). 
One expert that strongly believes in the use of medication for resting mental illness in 
children is Dr. Kiki Chang from Stanford University. Dr. Chang recently published an article in 
the Journal of Clinical Psychiatry regarding a study that he conducted involving kids from 
bipolar families. In this study, Dr. Chang took children from families that had a genetic 
predisposition and history of bipolar disorder, who had early signs and symptoms of the 
disorder. Each child was then given preemptive doses of a drug typically used to treat bipolar 
disorder called Depakote. The results of this study found that in 78% percent of the cases of this 
study, the children’s early symptoms were eased before the illness had ever even had a chance 
to take full effect (Kluger, 2008). 
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Dr. Chang states “you can sit and watch it (mental illness) develop or intervene and 
possibly prevent the disorder.” Although Dr. Chang remains extremely excited about the results 
of this study, he will also admit that the idea behind it is controversial. Many feel that it is 
ethically wrong to treat kids with medication who are not yet truly sick. Dr. Chang states 
“There’s a chance that some of the kids (in the study) might not develop bipolar (disorder) at 
all.” However he still feels more research is needed. He states “We need to have more genetics, 
more brain imaging, more biological markers in order to know which direction the kids are 
going.” (Kluger, 2008).  
Proving Their Case 
Much of society is also concerned with the effects that medication can have on a young 
brain. However, there is research that is beginning to shed light on that as well. Researchers 
and investigators have been looking more and more at different brain scans and using MRIs in 
order to determine the effects that medications have on a young brain.  
Previous research has shown that the brain volumes of children with ADHD are 3% 
smaller than those of children who do not have ADHD. This fact is initially very concerning 
because nearly all of the children involved in those scans had been taking medication for their 
ADHD. This leaves many to wonder if the decreased brain volume is a result of the the ADHD 
disorder itself or if it is a result of the medication the children had been taking for their ADHD 
(Kluger, 2008). 
One person attempting to answer this question is Dr. F. Xavier Castellanos of the New 
York University Child Studies Center. Dr. Castellanos decided to take his own scans and 
perform, his own study. In this study the children were separated into two groups. The first 
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group of children had ADHD and were not being treated for the disorder. The second group of 
children also had ADHD but were being treated with medication for their disorder. The results 
of this study found that both groups shared the same anatomical brain structure and therefore 
was able to determine that drugs were not the cause of a decrease in brain volume in the case 
of children with ADHD (Kluger, 2008). 
Dr. Steven Pliszka, Chief of Child Psychiatry at the University of Texas’ Health Center 
located in San Antonio, Texas decided to conduct his own study as well. Dr. Pliszka’s study was 
very similar in method to Dr. Castellanos’ study, however here were some minor differences. 
Like Dr. Castellanos’ study, Dr. Pliszka’s study included two groups of children. One group of 
children were diagnosed with ADHD but were not being treated for their disorder. The other 
group of children were also diagnosed with ADHD but had been taking medication as a form, of 
treatment for one year or longer (Kluger, 2008). 
The scans used in the conduction of this study not only picked up the anatomic structure 
of the children’s brains but examined their brain activity as well by means of blood flow. The 
results of this study were also very encouraging. Data showed that the group of children being 
treated for their ADHD with medication had no deficits regarding their brain structure or 
function in comparison to the group of children not being medicated. Additionally, Dr. Pliszka 
states that “we saw hints of improvement towards normal” in the brains of the children being 
medicated for ADHD (Kluger, 2008). 
 Despite these promising results, the conduction of these types of studies discussed are 
often very controversial. This is mostly due to the fact that within these studies one group of 
children that is known to have ADHD is not receiving treatment for it. Many feel that this is a 
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breach of ethical issues and standards. The doctors conducting these studies know that 
medication would help these children but withhold it from them possibly causing the children 
stress and harm. Experts and parents alike feel that it is wrong to withhold medication from a 
child who clearly needs it regardless of the situation (Kluger, 2008). 
Patient’s Thoughts 
 Much of society often looks towards the opinions of experts and doctors to determine 
what will benefit their children most. However, perhaps the most telling opinion comes from 
the children who grew up taking medication for their mental illness. One case study involving a 
girl named Andrea, certainly displays the positive effects that medication can have on a 
mentally ill child’s life. When Andrea was in 8th grade she was diagnosed with generalized 
anxiety, obsessive-compulsive disorder (OCD) and ADHD. All three disorders slowly began to 
take over Andrea’s life. Her school work suffered, her social life suffered and her family life 
suffered all due to mental illness (Kluger, 2008). 
 Today Andrea is a successful college freshman excited about her major of fashion 
merchandising. This is all thanks to the medication that she began taking for her illnesses. 
Andrea was placed on a pair of chemical stabilizing pills. The first medication is a drug called 
Lexapro which is an antidepressant and the second medication is a relatively new anti-ADHD 
drug called Adderall. Andrea states that it is due to these medications that she feels “excited 
about things.” Andrea goes on to say “I feel like I got me back.” (Kluger, 2008). 
Although this would sound like an easy fix and a story with a happy ending, there is still 
more to it. The antidepressant drug that Andrea has been taking called Lexapro, works by 
artificially manipulating and changing the chemicals of the brain that are responsible for feeling 
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and thought. The long term consequences that staying on a drug like this could cause are still 
unknown. Additionally, the drug Adderall has left Andrea with side effects of weight loss and 
sleeplessness. But the real question is, how does Andrea feel about her situation knowing what 
her treatment has caused? Andrea says  
“I’m just glad there were things that could be done.” (Kluger, 2008). 
Another case study of a young girl named Monica discusses her experience with 
medication as a child. Monica was raised by her grandmother due to the fact that her mother 
had bipolar disorder. At the age of 6, it was clear that Monica had developed the disorder as 
well. Initially, doctors prescribed 6 year old Monica a combination of Ritalin and Prozac. When 
it became clear that this drug combination was not working, doctors switched her to Zyprexa 
which is an antipsychotic, at the age of 8. Unfortunately this medication led to a side effect of 
serious weight gain. By the time Monica was 12 she had stretch marks from the excessive 
weight her body was now suddenly taking on. So her doctors switched her medication regimen 
once again (Kluger, 2008). 
Today Monica is taking a combination of four different drugs. This combination includes 
Tegretol, which is an anticonvulsant and Abilify which is an antipsychotic. Luckily for Monica 
and her grandmother, this combination of medications seems to be helping Monica 
tremendously. Monica’s grandmother says “She’s the best I’ve ever seen her. She’s smiling, her 
moods are consistent. I’m cautiously optimistic. Monica seems to agree with her grandmother 
that this medication has helped her immensely. Now 13, Monica states “I’m in a better mood.” 
(Kluger, 2008). 
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The case study of Jonathan, who is now 18, is also a case for medication. Jonathan 
described his experience with mental illness prior to medication as such; “I knew that 
something was wrong, but I didn’t know what. I felt like there was this big black fog in my brain 
that I couldn’t fix.” As an adolescent, Jonathan received the diagnosis of major depression. The 
treatment for this disorder in his case was a drug called Zoloft. Today, Jonathan feels much 
differently. He feels that he has much more energy and focus. He has also experienced an 
improvement in his grades and is taking better care of himself. Jonathan’s mother sees the 
change as well. She says “He has the look of someone who has come back to life.” (Kluger, 
2008). 
Implications for Social Workers 
 Many of the professionals working with medicated youth such as doctors and 
psychiatrists, have been discussed thus far. However, it is social workers that provide the 
largest proportion of mental health services in the United States. Additionally, many studies 
have shown that nearly every social worker practicing with youths has worked with a 
medicated child or adolescent (Moses & Kirk, 2006). In a recent survey of social workers, only 
6% of survey respondents reported that none of their clients used psychotropic medication. 
This means that nearly all social workers will encounter client taking psychotropic medication at 
some point during their career (Farmer, Bentley & Walsh, 2006). Therefore, it is safe to say that 
these increases and changes within the mental health community have had and will have a 
great effect on the social work profession.  
These statistics, including the statistics on the increase of medication use in children, 
could potentially mean many things for the future of social work professionals. For example, we 
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know that the number of children on medication is growing. Therefore the demand of social 
workers in the mental health field will also increase. There may also be an increase of social 
workers needed to work with children in the future due to these changes. But, perhaps the 
largest effect that this increase is having and will continue to have on the social work profession 
is adding teachings on the use of medications in clients top the social work curriculum (Farmer, 
Bentley & Walsh, 2006). 
Some changes that have already begun and are able to be seen is the sheer number of 
social work clients that are on psychotropic medications. Nowadays, social workers often times 
work with clients who are currently being prescribed several medications. This has a great 
effect on a social workers intervention strategy with that clients and often times makes it much 
more complex. It is with these changes that the role of a social worker has begun to change and 
expand in order to meet the demands of clients. Today, social workers are expected to do more 
and more of which they were not in previous years. Although the expectations of what a social 
worker is equipped to handle has changed, the curriculum of a social work student has not yet 
changed to meet this demand (Farmer, Bentley & Walsh, 2006). 
As stated previously, social workers are the largest group of professionals that work in 
the mental health field and seldom have a client that is not on a type of psychotropic 
medication. However, when examining the typical social work curriculum there are no such 
classes on psychotropic medication to be found. In a study performed by the Council on Social 
Work Education it was found that only 44% of social work programs included “some content on 
psychopharmacology.” However, it appeared that most of this content was taught in elective 
courses and the extent of this content varied upon individual faculty interest. Additionally, 54% 
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of social work programs reported having “no classroom content on psychopharmacology.”Of all 
the social work programs surveyed, 55% stated that all schools of social work should include 
content on psychopharmacology in their curricula and that all students should be exposed to it  
(Farmer, Bentley & Walsh, 2006).  
Although many schools do not include this type of teachings or course into their 
curricula, there are a few that have begun to make changes and add it in. Virginia 
Commonwealth University has offered an elective in psychopharmacology for the last 8 years. 
Additionally, the university has added in a unit on psychopharmacology to its Human Behavior 
in the Social Environment course for the last 2 years. Since Human Behavior is a required course 
for social work students, all students in the social work program, and not just those taking the 
elective, were exposed to this type of content (Farmer, Bentley & Walsh, 2006). 
Virginia Commonwealth University has stated that this type of content has been very 
well received by the students. Many social work students at the university had already had a 
previous interest in the topic of psychopharmacology either professionally or personally. This 
information fits along with a recent study which found that depression and anxiety were 
extremely common among social work students. This type of interest really enhanced the 
learning experience at Virginia Commonwealth. It was reported that students actively 
participated in class lectures and discussions. AT the end of the course, students reported 
feeling much more confident in working with clients who use psychotropic medications 
(Farmer, Bentley & Walsh, 2006).  
Due to the fact that social workers have been experiencing an increased demand as 
professionals to understand psychotropic medications and yet, there has been little attempt to 
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add teachings regarding these medications into social work curricula, it is important to ask; 
where have social workers been getting the knowledge to handle these clients? A 2001 national 
survey of clinical social workers determined that more than 95% of social workers cited their 
top sources of knowledge on psychopharmacology as collaboration with physicians, 
interactions with clients, conversations with peers and professional workshops. Much lower 
down the list of responses as a source of knowledge was an MSW program at 71% and a BSW 
program at only 16% (Farmer, Bentley & Walsh, 2006). 
These social workers were then asked about the quality of knowledge that they felt they 
had received in their program. Of those in an MSW program only 21% of respondents stated 
that their program was a “good” or “excellent” source of knowledge. Of those in a BSW 
program, only 2% of respondents stated that their program was a “good” or “excellent” source 
of knowledge (Farmer, Bentley & Walsh, 2006). According to an article published in the Journal 
or Social Work Education, it is common for social workers to have learned about psychiatric 
medications from their field placements during baccalaureate or master of social work 
programs or from employment experiences. In a different study performed by the Council on 
Social Work Education that surveyed 994 clinical social workers, it was found that a majority of 
social work professionals learn about psychiatric medications mainly from collaborations with 
physicians (Farmer, Bentley & Walsh, 2006). 
This lack of a structured and streamlined education on the subject of 
psychopharmacology among social work students could lead to many problems in the future. 
For example, if a social worker is unaware of certain medications and the effects that they may 
have on a client, they are less likely to make the best judgement calls for interventions. With 
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the curriculum that is currently in place where psychopharmacology is not a required course, 
the amount on the subject that social workers know and what was covered on the subject 
varies from each individual based on the school they attended. This could potentially cause 
problems in the workplace if a majority of the workers at that agency have all received very 
little formal education on the subject (Farmer, Bentley & Walsh, 2006). 
Due to the fact that it is well agreed upon that in order to practice competently and 
effectively, social workers must be exposed to knowledge on psychopharmacology. Therefore 
the Journal of Social Work Education has created a seven module curriculum  proposal to use in 
social work education. These modules provide specific content that can be integrated into 
almost any pre-existing social work course and does not require an entire course to cover all of 
the topic areas included. The modules are titled as follows: Module 1: The social worker’s role 
in psychopharmacology, Module 2: Principles of Drug Action, Module 3: Classes and Types of 
Psychotropic Medication, Module 4: Psychopharmacology with Special Populations, Module 5: 
Ethical and Legal Issues with Psychopharmacology, Module 6: Medication Management 
Techniques and Module 7: Interdisciplinary Collaboration. Each module includes goals and 
objectives for students by the end of each module and is designed to give social workers 
knowledge on psychopharmacology that is relative to their future work (Farmer, Bentley & 
Walsh, 2006).  
Additionally, the Journal of SOcial Work education suggests that the seven modules 
previously mentioned are used in application to field work courses. Since it is already proven 
that a majority of social workers come in contact with clients who are taking psychotropic 
medications, field placements are an opportune time to put the modules into effect. By giving 
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students the opportunity to then apply the knowledge that they have gained in their 
psychopharmacology lessons, they are further learning how to apply and use the knowledge 
in  professional and real life situations (Farmer, Bentley & Walsh, 2006). 
The increase of children and youth being medicated is causing the values and therefore, 
the practices of professional social workers to change as well. A social worker’s attitude on drug 
treatment is very important because it can likely affect their behavior and communication style 
with parents (Moses & Kirk, 2006). According to a recent study, the majority of social workers 
had a very validating attitude about towards children and the parents of children taking 
medication for mental disabilities. Only a very small amount had a parent-blaming view 
towards the children and their parents (Johnson, 1998). 
However, this was not always the case. In years past, social workers tended to have an 
anti-medication practice belief. Much of the social work literature from the 1970’s and 1980’s 
depicts the professions view of psychotropic medications as “suspicious and negative.” Much of 
this literature focused on things such as overmedication, inadequate screening, infringement of 
patient rights and side effects. Today, social work literature in fact suggests that professionals 
subscribe to the medical model and support as well as facilitate the use of drug treatment for 
those with mental illness. Several other studies have concluded that today’s social workers are 
more positive about drug treatment than other mental health professionals (Moses & Kirk, 
2006). This is most likely due to the increase of clients and thus, experience, that social workers 
have had with drug treatment in regards to mental illness. 
This increase in social worker’s positive attitudes regarding drug treatment can also be 
seen in a 1998 study completed by Johnson and Associates. This study concluded that the 
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majority of those with a positive attitude regarding drug use were from a more recent younger 
generation and those with a negative attitude were older social workers who had been working 
for longer and therefore would have been studying social work at a much earlier time. These 
social workers’ attitudes likely stem from what they were taught in school and the clients that 
they had been exposed to throughout their career (Moses & Kirk, 2006). 
Another study specifically asked social workers to identify their feelings towards the use 
of psychopharmacology with youth. The results of this study concluded that respondents 
tended to disagree with the idea that psychopharmacology in generally harmful for youths. 
Therefore, social workers are becoming increasingly accepting of medicating clients that are 
younger. However, many social workers in the study agreed that medication is often times used 
as a substitute in which other treatments could be used (Moses & Kirk, 2006).  
Solution of Combination 
There are many studies that point to such other treatment options as being more 
effective in treating patients with mental illness. However, many patients and doctors will shy 
away from these other treatment options as they take more time for results to be seen. Still, 
many argue that these other forms of treatment are better for patients in the long run due to 
their less invasive nature to the body and proof of extreme success. These other types of 
therapies are referred to as psychosocial therapies, also known as talk or behavioral therapies. 
These types of therapies work on changing the behavior of an individual and teaching coping 
strategies for an individual’s mental illness (National Institute of Mental Health, 2013). 
Cognitive behavioral therapy is another is another type of psychotherapy that is 
extremely effective when working with children. This form of treatment has been studied 
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numerous times has proven to be effective in treating a number of conditions in children such 
as depression, obsessive-compulsive disorder and social anxiety. Cognitive behavioral therapy 
works with children to change their distorted thinking patterns and unhealthy behaviors 
associated with their illness. Cognitive Behavioral Therapy goes along with the idea that many 
professionals have which is that medication should be used with other treatments and should 
not be the only treatment (National Institute of Mental Health, 2013). 
There are also many effective psychosocial therapies for children suffering from ADHD. 
Two of these include behavioral parent training and behavioral classroom management. These 
psychosocial therapies as well as the ones previously mentioned, can be utilized in combination 
with each other in order to achieve optimal results. For example, a child with ADHD could 
receive both behavioral classroom management and cognitive behavioral therapy 
simultaneously. Psychosocial therapies work by providing children with new skills while also 
increasing overall mental health (National Institute of Mental Health, 2013).  
Although medication alone is a proven treatment for ADHD, a 14 month study 
conducted by the National Institute of Mental Health concluded that combining behavioral 
treatment with medication was more effective in other areas. Some of these areas include the 
improvement of families, teachers and children in their ability to modify the behaviors 
associated with ADHD that cause problems and home and at school. Additionally, some of the 
children receiving both medication along with behavioral treatment were able to take lower 
doses of the medicine than children receiving the medicine as the sole treatment. The 
behavioral treatments utilized in this study were parent training, child-focused treatment and 
school-based interventions. The study also concluded that the combined treatment of 
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medication and behavioral therapy was especially effective in treating children with ADHD and 
other combining disorders such as depression or anxiety (Children, 2013). 
Other professionals in the field strongly suggest that children with other mental illnesses 
try and receive psychotherapy as a treatment option. Many of these professionals suggest 
psychotherapy as the initial treatment option for children and adolescents with major 
depressive disorder, especially those with milder cases. This is often the suggestion due to the 
fact that psychotherapy is also an effective way to determine the severity and persistence of 
the individual’s depression and can help in the decision of if medication is warranted. Cognitive 
behavioral therapy is a very effective psychotherapy when working with those suffering from 
depression. Interpersonal therapy is another very effective form of treatment when working 
with those suffering from depression. Interpersonal therapy helps individuals understand and 
work through any troubled personal relationships that they may have as these can often times 
be the cause of or adding to the individual’s depressive state (Children, 2013). 
The National Institute of Mental Health performed another study to determine the best 
treatment options for adolescents with depression. This major clinical trial was titled the 
Treatment for Adolescents with Depression Study. This study used 439 adolescents ages 12-17 
all suffering from major depressive disorder. The adolescents were then separated into four 
treatment groups. One group received a combination of fluoxetine (Prozac), a common SSRI 
used to treat depression and cognitive behavioral therapy. The second group received 
fluoxetine only. The third group received cognitive behavioral therapy only and the fourth 
group received a placebo only. After 12 weeks, 71% of the individuals responded best to the 
combination of fluoxetine and cognitive behavioral therapy. Additionally, 61% responded to the 
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fluoxetine only treatment, 43% responded to the cognitive behavioral therapy only treatment 
and 35% responded to the placebo only treatment. The results of this study have indicated that 
a combination of medication and psychotherapy is the most is the most effective form of 
treatment for adolescents with depression. The study also concluded that of all four groups, 
those receiving medication along with psychotherapy, showed the greatest reduction in suicidal 
thinking (Antidepressants, 2013).  
Many groups are also trying to educate parents about the psychotherapy treatment 
options that are available for their children to be either used along with or in place of 
medication. For example, a guide for parents with children suffering from bipolar disorder 
explains that there are many different treatment options available for their children, all of 
which are proven to be effective. This guide for parents stresses that psychotherapy is equally 
as important as medication in helping a child manage their illness. The same section of this 
guide also explains the objectives of such psychotherapy treatment options and what they can 
provide. The guide stresses that the education of family and behavioral management 
techniques that are gained throughout psychotherapy are crucial in helping a child stay on the 
treatment program and helping to prevent relapse. The guide also cited a recent two year long 
study that concluded psychotherapy that focused on interpersonal coping strategies of children 
with bipolar disorder, greatly helped in controlling the symptoms of the disorder and allowing 
the children to function better in society (Parents’ Medguide, 2013).  
Projections 
 After taking the findings of this research into account, it is fairly easy to see where the 
trends of this topic will go in the future. Many of the articles and journals involved in this 
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research have projected that the amount of children being diagnosed with mental illnesses will 
continue to rise. Specifically, the number of those diagnosed with ADHD will continue to rise 
even further. Along with these increases will be a similar increase in the amount of children on 
medication for these illnesses. Due to these increases, the amount of professional social 
workers collaborating with psychiatrists will also continue to increase. Following all of the 
research being done on social work curriculums it can be predicted that many social work 
programs will utilize the addition of a psychopharmacology course.  
Conclusion 
 The majority of children being treated for mental illness are staggering. Unfortunately, 
due to limitations of what research can be performed on children, there is a significant lack of 
understanding regarding the effects that medication has on a young brain. More research is 
desperately needed in order to determine future and long term effects that these statistics may 
have. The social work profession will continue to be the largest group of professionals treating 
mental illness. Social work students need to be taught more about the medications being used 
by their clients in order to create better intervention strategies that will help their clients more 
effectively. The amount of children with mental illness is only going to rise further. It is 
important that parents understand the risks and rewards of medicating their children. It is also 
important that more parents and professionals are educated on the benefits that other 
psychotherapies can offer as far as treatment options.  
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